We came across a bullish thesis on Enovis Corporation on Value investing subreddit by TheBestOfAllTylers. In this article, we will summarize the bulls’ thesis on ENOV. Enovis Corporation's share was trading at $24.66 as of January 13th. ENOV’s forward P/E was 6.85 according to Yahoo Finance. wavebreakmedia/Shutterstock.com Enovis operates as a specialized challenger platform in musculoskeletal healthcare, combining a high-margin, surgeon-driven implant franchise with a faster-turning but lower-margin pr ...